Baclofen Treatment of Ataxia Telangiectasia

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Ataxia Telangiectasia

In brief

This research is being done to find out if Baclofen, a medicine that is often used for the treatment of abnormal stiffness, might also be useful to treat some of the neurologic problems caused by ataxia telangiectasia (A-T). The investigators also want to find out if there are better ways to measure the problems of ataxia and abnormal eye movement for future studies of medication in ataxia telangiectasia.

Key facts

Study ID

NCT00640003

Run by

Johns Hopkins University

People needed

10

Starts

2007-04-01

Expected to finish

2011-02-01

Last updated by the study team

2017-12-20

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Teenagers over 12 years old and young adults with A-T may join if they have been evaluated previously in the A-T Clinical Center at Johns Hopkins Hospital and have a measurable abnormality of eye movement.
• Patients who are presently taking Baclofen will be eligible for the study if they are presently receiving the medication under the direction of Dr. Crawford in the ATCC, and are willing to withdraw from the medication for a period of one month prior to the initial screening visit.
• Female patients who are sexually active will be given a standard serum HCG pregnancy test.
• Those who are sexually active will be counseled about necessary precautions against pregnancy during the duration of the trial.

You may not qualify if…

• A positive pregnancy test.

Where it is running

• Johns Hopkins Hospital — Baltimore, Maryland, United States
• Johns Hopkins Hospital — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.